Literature DB >> 20827454

[Hepatocellular carcinoma and cholangiocarcinoma].

F Rauchfuss1, H Scheuerlein, M Götz, Y Dittmar, R Voigt, M Heise, U Settmacher.   

Abstract

Hepatocellular carcinoma and cholangiocarcinoma are relatively rare tumors of the gastrointestinal tract in western Europe but their incidence has been increased in recent years. Newly diagnosed intrahepatic lesions or intrahepatic cholestasis require extensive laboratory tests and imaging studies in order to confirm the diagnosis of hepatocellular carcinoma, intrahepatic or extrahepatic cholangiocarcinoma. The treatment options range from liver resection or liver transplantation to conservative measures (in cases of non-resectable lesions). This review article aims to provide an overview on the diagnostic options and the subsequent treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827454     DOI: 10.1007/s00104-009-1864-z

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  73 in total

Review 1.  PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients.

Authors:  Keigo Endo; Noboru Oriuchi; Tetsuya Higuchi; Yasuhiko Iida; Hirofumi Hanaoka; Mitsuyuki Miyakubo; Tomohiro Ishikita; Keiko Koyama
Journal:  Int J Clin Oncol       Date:  2006-08       Impact factor: 3.402

Review 2.  Mechanism of impaired hepatic regeneration in cholestatic liver.

Authors:  Yukihiro Yokoyama; Masato Nagino; Yuji Nimura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-03-27

Review 3.  Evaluation and endoscopic palliation of cholangiocarcinoma. Management of cholangiocarcinoma.

Authors:  A Rumalla; T H Baron
Journal:  Dig Dis       Date:  1999       Impact factor: 2.404

4.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

Review 5.  Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.

Authors:  Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

6.  Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET.

Authors:  A Kornberg; B Küpper; K Thrum; J Wilberg; A Sappler; D Gottschild
Journal:  Am J Transplant       Date:  2009-09-22       Impact factor: 8.086

Review 7.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

8.  Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study.

Authors:  Alessandro Ferrero; Luca Viganò; Roberto Polastri; Andrea Muratore; Haris Eminefendic; Daniele Regge; Lorenzo Capussotti
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

Review 9.  Advances in the diagnosis, evaluation and management of cholangiocarcinoma.

Authors:  Pankaj Singh; Tushar Patel
Journal:  Curr Opin Gastroenterol       Date:  2006-05       Impact factor: 3.287

10.  Surgical treatment of cholangiocellular carcinoma.

Authors:  R Pichlmayr; P Lamesch; A Weimann; G Tusch; B Ringe
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

View more
  1 in total

1.  Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.

Authors:  Felix Dondorf; René Fahrner; Michael Ardelt; Eleonora Patsenker; Felix Stickel; Uta Dahmen; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.